Who was studied, and how
One number in the abstract
Where each one falls
Where it lands on the map
885people with type 2 diabetes, in this paper
The trial randomly assignedassigned by chance
pioglitazone add-on therapy
metformin and dapagliflozin
Probably lowered HbA1c levels−0.41
randomisedthe abstract, start to end
… significantly reduced HbA1c levels (MD: -0.41; 95% CI: -0.54 to -0.27, …
← favours treatmentfavours comparator →
could be chanceHbA1c levelspioglitazone add-on therapy vs metformin and dapagliflozin
−0.41−0.54 to −0.27
ThiazolidinedionesGlycemic control
1 / 4